Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pozenel

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Die Medizinische Welt|June 12, 1981
[Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil]H Pozenel
Cardiology|January 1, 1982
Hemodynamic effects of calcium antagonists in cardiac patientsH Pozenel
Die Medizinische Welt|February 9, 1979
[Bromazepam lowers the blood pressure in hypertensive patients]H Pozenel, A Bückert, R Amrein
International Journal of Clinical Pharmacology and Biopharmacy|January 1, 1977
The antihypertensive effect of lexotan (bromazepam)- a new benzodiazepine derivativeH Pozenel, A Bückert, R Amrein
Wiener Medizinische Wochenschrift (1946)|April 30, 1988
[Problems of medical documentation in the hospital]M Rossoll, H Pozenel, H Gogl
Journal of Clinical Pharmacology|April 1, 1984
Pharmacokinetics and hemodynamic effects of tiapamil: exercise performance, thallium stress scintigraphy, and radionuclide ventriculographyM Eckert, H Pozenel, B Pillat
Wiener Klinische Wochenschrift|March 19, 1976
[Blood pressure analysis by means of an ultrasonic blood pressure monitor during the course of rehabilitative treatment (author's transl)]G Ott, H Pozenel, W Ritschel
MMW, Munchener Medizinische Wochenschrift|June 3, 1983
[Indications for radionuclide ventriculography]C Delagardelle, H Pozenel, W E Adam
Clinical Pharmacology and Therapeutics|September 1, 1992
Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertensionR Schmitt, C H Kleinbloesem, G G Belz, et al.
Clinical Pharmacology and Therapeutics|November 1, 1993
Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertensionG A Rongen, J W Lenders, C H Kleinbloesem, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Die Medizinische Welt|June 12, 1981
[Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil]H Pozenel
Cardiology|January 1, 1982
Hemodynamic effects of calcium antagonists in cardiac patientsH Pozenel
Die Medizinische Welt|February 9, 1979
[Bromazepam lowers the blood pressure in hypertensive patients]H Pozenel, A Bückert, R Amrein
International Journal of Clinical Pharmacology and Biopharmacy|January 1, 1977
The antihypertensive effect of lexotan (bromazepam)- a new benzodiazepine derivativeH Pozenel, A Bückert, R Amrein
Wiener Medizinische Wochenschrift (1946)|April 30, 1988
[Problems of medical documentation in the hospital]M Rossoll, H Pozenel, H Gogl
Journal of Clinical Pharmacology|April 1, 1984
Pharmacokinetics and hemodynamic effects of tiapamil: exercise performance, thallium stress scintigraphy, and radionuclide ventriculographyM Eckert, H Pozenel, B Pillat
Wiener Klinische Wochenschrift|March 19, 1976
[Blood pressure analysis by means of an ultrasonic blood pressure monitor during the course of rehabilitative treatment (author's transl)]G Ott, H Pozenel, W Ritschel
MMW, Munchener Medizinische Wochenschrift|June 3, 1983
[Indications for radionuclide ventriculography]C Delagardelle, H Pozenel, W E Adam
Clinical Pharmacology and Therapeutics|September 1, 1992
Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertensionR Schmitt, C H Kleinbloesem, G G Belz, et al.
Clinical Pharmacology and Therapeutics|November 1, 1993
Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertensionG A Rongen, J W Lenders, C H Kleinbloesem, et al.
Pageof 3